Literature DB >> 2864052

Intrinsic sympathomimetic activity of cardioselective beta-adrenoceptor blockers and effects on renal function.

I G Mackay, A M Macnicol, H J Smith, A D Cumming, M L Watson.   

Abstract

The effects of a 21 infusion of isotonic sodium chloride on renal haemodynamics and sodium excretion were measured in nine normotensive volunteers. Changes in these responses to volume expansion induced by cardioselective beta-adrenoceptor blockade by drugs with (epanolol) and without intrinsic sympathomimetic activity (atenolol) were examined. Renal plasma flow was significantly lower before, during and after sodium chloride infusion whilst on treatment with atenolol compared with epanolol. Urinary sodium excretion was lower on atenolol than epanolol. Glomerular filtration rate was unchanged by either drug. Basal urinary kallikrein excretion was diminished by atenolol and both epanolol and atenolol inhibited the rise in urinary kallikrein excretion after sodium chloride infusion. Although some of these findings may be due to a more potent hypotensive effect of atenolol, intrinsic sympathomimetic activity may contribute to the apparent protective effects of epanolol on renal function.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2864052      PMCID: PMC1400691          DOI: 10.1111/j.1365-2125.1985.tb05061.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  29 in total

1.  [Editorial: Importance of cardioselectivity and sympaticomimetric potential of beta-blockers (author's transl)].

Authors:  U C Dubach
Journal:  Schweiz Rundsch Med Prax       Date:  1975-09-30

2.  Urinary kallikrein excretion in normal man. Relationships to sodium intake and sodium-retaining steroids.

Authors:  H S Margolius; D Horwitz; R G Geller; R W Alexander; J R Gill; J J Pisano; H R Keiser
Journal:  Circ Res       Date:  1974-12       Impact factor: 17.367

3.  Changes in glomerular filtration rate during long-term treatment with propranolol in patients with arterial hypertension.

Authors:  H Ibsen; P Sederberg-Olsen
Journal:  Clin Sci       Date:  1973-02       Impact factor: 6.124

4.  Effects of chronic beta-adrenergic blockade on systemic and renal haemodynamic responses to hyperosmotic saline in hypertensive patients.

Authors:  X H Krauss; M A Schalekamp; G Kolsters; G A Zaal; W H Birkenhäger
Journal:  Clin Sci       Date:  1972-09       Impact factor: 6.124

5.  Mechanism of increased sodium reabsorption during propranolol administration.

Authors:  A S Nies; J S McNeil; R W Schrier
Journal:  Circulation       Date:  1971-10       Impact factor: 29.690

6.  Intrarenal pressure and exaggerated natriuresis in essential hypertension.

Authors:  J Lowenstein; E R Beranbaum; H Chasis; D S Baldwin
Journal:  Clin Sci       Date:  1970-03       Impact factor: 6.124

7.  Application of Heyrovsky's inulin method to automatic analysis.

Authors:  J K Dawborn
Journal:  Clin Chim Acta       Date:  1965-07       Impact factor: 3.786

8.  Studies on the mechanism of hypernatriuresis in essential hypertension in relation to measurements of plasma renin concentration, body fluid compartments and renal function.

Authors:  M A Schalekamp; X H Krauss; M P Schalekamp-Kuyken; G Kolsters; W H Birkenhäger
Journal:  Clin Sci       Date:  1971-09       Impact factor: 6.124

9.  Changes in renal function in essential hypertension.

Authors:  F C Reubi; P Weidmann; J Hodler; P T Cottier
Journal:  Am J Med       Date:  1978-04       Impact factor: 4.965

10.  The effect of beta adrenergic blockade on patterns of urinary sodium excretion. Studies in normal subjects and in patients with heart disease.

Authors:  S E Epstein; E Braunwald
Journal:  Ann Intern Med       Date:  1966-07       Impact factor: 25.391

View more
  2 in total

Review 1.  Clinical pharmacology of epanolol. Pharmacodynamic aspects.

Authors:  J D Harry
Journal:  Drugs       Date:  1989       Impact factor: 9.546

2.  The effects of selective beta-adrenoceptor antagonists and partial agonist activity on renal function during exercise in normal subjects and those with moderate renal impairment.

Authors:  D Taverner; I G Mackay; K Craig; M L Watson
Journal:  Br J Clin Pharmacol       Date:  1991-09       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.